These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 33685081)
1. [Retrospective analysis of risk factors of liver cirrhosis combined with overt hepatic encephalopathy: a single -center case-control study]. Fan YN; Ji TT; Liang RY; Yu YY; Xu JH Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):133-136. PubMed ID: 33685081 [No Abstract] [Full Text] [Related]
2. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J; J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis. Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of clinical characteristics and risk factors for nosocomial mortality in patients with liver cirrhosis combined with atrial arrhythmia]. Ren JY; Yan MM; Li XT; Liu H; Tang NE; Zheng RJ; Lu XB Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):453-460. PubMed ID: 38858195 [No Abstract] [Full Text] [Related]
5. [Clinical characteristics of 500 hospitalized patients with liver cirrhosis: a retrospective analysis from a tertiary hospital in Beijing]. Xu JH; Fan YN; Ji TT; Liang RY; Yu YY Zhonghua Gan Zang Bing Za Zhi; 2022 May; 30(5):541-545. PubMed ID: 35764547 [No Abstract] [Full Text] [Related]
6. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score. Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis: A retrospective cohort study. Miwa T; Hanai T; Hirata S; Nishimura K; Sahashi Y; Unome S; Imai K; Shirakami Y; Suetsugu A; Takai K; Shimizu M Clin Nutr ESPEN; 2024 Oct; 63():267-273. PubMed ID: 38972037 [TBL] [Abstract][Full Text] [Related]
8. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis. Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656 [TBL] [Abstract][Full Text] [Related]
9. Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. Jepsen P; Watson H; Andersen PK; Vilstrup H J Hepatol; 2015 Nov; 63(5):1133-8. PubMed ID: 26206073 [TBL] [Abstract][Full Text] [Related]
10. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation. Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778 [TBL] [Abstract][Full Text] [Related]
11. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis. Miwa T; Hanai T; Nishimura K; Maeda T; Ogiso Y; Imai K; Suetsugu A; Takai K; Shiraki M; Shimizu M JPEN J Parenter Enteral Nutr; 2022 May; 46(4):858-866. PubMed ID: 34287991 [TBL] [Abstract][Full Text] [Related]
12. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices. Dong TS; Kalani A; Aby ES; Le L; Luu K; Hauer M; Kamath R; Lindor KD; Tabibian JH Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1894-1901.e1. PubMed ID: 30708109 [TBL] [Abstract][Full Text] [Related]
13. Severity of Non-B and Non-C Hepatitis Versus Hepatitis B and C Associated Chronic Liver Disease: A Retrospective, Observational, Comparative Study. Asghar MS; Ahsan MN; Rasheed U; Hassan M; Jawed R; Abbas MB; Yaseen R; Ali Naqvi SA; Rizvi H; Syed M Cureus; 2020 Dec; 12(12):e12294. PubMed ID: 33520498 [TBL] [Abstract][Full Text] [Related]
14. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380 [TBL] [Abstract][Full Text] [Related]
15. A double blind randomized controlled trial to assess efficacy of nutritional therapy for prevention of recurrence of hepatic encephalopathy in patients with cirrhosis. Ahuja H; Sharma BC; Sachdeva S; Mahajan B; Sharma A; Bara S; Srivastava S; Kumar A; Dalal A; Sonika U J Gastroenterol Hepatol; 2023 Mar; 38(3):433-440. PubMed ID: 36574769 [TBL] [Abstract][Full Text] [Related]
16. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845 [TBL] [Abstract][Full Text] [Related]
17. [Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]. Zhao JM; Zhang L; Du QW; Mu CQ; Ren YL; Hu LP; Shen G; Zhuang LW; Lu Y; Qiu GH; Sun QF; Wu YZ; Yang M; Li MH; Xie Y; Cheng J; Xu DZ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):366-9. PubMed ID: 24645325 [TBL] [Abstract][Full Text] [Related]
18. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Barone M; Shahini E; Iannone A; Viggiani MT; Corvace V; Principi M; Di Leo A Dig Liver Dis; 2018 May; 50(5):496-500. PubMed ID: 29530628 [TBL] [Abstract][Full Text] [Related]
19. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation. Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772 [TBL] [Abstract][Full Text] [Related]
20. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J; Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]